BSF

FreezeM Raises $14.2M in Series A to Accelerate Market Expansion in the Insect Protein Industry

Retrieved on: 
Thursday, February 15, 2024

NAHSHONIM, Israel, Feb. 15, 2024 /PRNewswire/ -- FreezeM, an Agri-tech pioneering biotechnology company that offers Breeding-as-a-Service (BaaS) for Black Soldier Fly (BSF) protein factories, announced today the closure of $14.2 million in Series A funding. The funding round was led by a group of seasoned industrial investors and the prestigious European Innovation Council Fund (EIC Fund), along with FreezeM's existing investors and partners. The funding will be used to accelerate the growth of the company's breeding hubs network and commercialize its novel solutions at scale, accommodating the rapidly increasing market demand.

Key Points: 
  • Traditionally BSF breeding is a major bottleneck in industrial scale insect protein production, requiring unique bio-expertise to tackle inherent colony instabilities and technological gaps.
  • By eliminating these industry constraints, PauseM® not only promotes sector growth but also facilitates scaling of the global insect protein industry.
  • FreezeM takes the breeding hurdle out of the equation, streamlining insect protein production and making it more efficient and accessible from new entrants to veteran market players.
  • Our technology unleashes the insect market from its shackles and will propel the insect protein market to fulfill its true potential," said Dr. Yuval Gilad, Co-founder and CEO of FreezeM.

FreezeM Raises $14.2M in Series A to Accelerate Market Expansion in the Insect Protein Industry

Retrieved on: 
Thursday, February 15, 2024

NAHSHONIM, Israel, Feb. 15, 2024 /PRNewswire/ -- FreezeM, an Agri-tech pioneering biotechnology company that offers Breeding-as-a-Service (BaaS) for Black Soldier Fly (BSF) protein factories, announced today the closure of $14.2 million in Series A funding. The funding round was led by a group of seasoned industrial investors and the prestigious European Innovation Council Fund (EIC Fund), along with FreezeM's existing investors and partners. The funding will be used to accelerate the growth of the company's breeding hubs network and commercialize its novel solutions at scale, accommodating the rapidly increasing market demand.

Key Points: 
  • Traditionally BSF breeding is a major bottleneck in industrial scale insect protein production, requiring unique bio-expertise to tackle inherent colony instabilities and technological gaps.
  • By eliminating these industry constraints, PauseM® not only promotes sector growth but also facilitates scaling of the global insect protein industry.
  • FreezeM takes the breeding hurdle out of the equation, streamlining insect protein production and making it more efficient and accessible from new entrants to veteran market players.
  • Our technology unleashes the insect market from its shackles and will propel the insect protein market to fulfill its true potential," said Dr. Yuval Gilad, Co-founder and CEO of FreezeM.

BIGG Digital Assets Announces the Appointment of Fraser Matthews to its Board of Directors

Retrieved on: 
Tuesday, February 13, 2024

VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins , Blockchain Intelligence Group and TerraZero is pleased to announce the appointment of Fraser Matthews to its Board of Directors.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins , Blockchain Intelligence Group and TerraZero is pleased to announce the appointment of Fraser Matthews to its Board of Directors.
  • Fraser joined the BIGG team on June 7, 2022, as the President of Netcoins.
  • Fraser brings tremendous business acumen, experience and keen insights at the management level - all of which will translate well at the Board level.
  • Fraser has been working exclusively in the Financial Services industry for the last 17 years having held positions in Toronto, New York, London and Dubai.

Power Generation Gain Reached 6.86%, Empirical Data of Risen Energy's HJT Hyper-ion Module in Yinchuan and Hainan Released by CPVT

Retrieved on: 
Thursday, February 8, 2024

Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.

Key Points: 
  • Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.
  • Risen Energy collected the power generation data of HJT Hyper-ion modules and the PERC modules at Hainan base in 2023Q4.
  • The empirical performance of the HJT Hyper-ion modules at CPVT Hainan base aligns closely with our simulation results, indicating a 5.51% higher power generation compared to PERC modules.
  • Risen Energy's empirical projects are currently well under way, and the company will continue to disclose the empirical data as it is updated and released.

Power Generation Gain Reached 6.86%, Empirical Data of Risen Energy's HJT Hyper-ion Module in Yinchuan and Hainan Released by CPVT

Retrieved on: 
Thursday, February 8, 2024

Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.

Key Points: 
  • Figure 1 compares the power generation data of the HJT Hyper-ion modules and the PERC modules at the empirical study base in Yinchuan in 2023Q4.
  • Risen Energy collected the power generation data of HJT Hyper-ion modules and the PERC modules at Hainan base in 2023Q4.
  • The empirical performance of the HJT Hyper-ion modules at CPVT Hainan base aligns closely with our simulation results, indicating a 5.51% higher power generation compared to PERC modules.
  • Risen Energy's empirical projects are currently well under way, and the company will continue to disclose the empirical data as it is updated and released.

The Barth Syndrome Foundation Delivers Petition to FDA Advocating for a Fair, Equitable and Appropriate Review of the Only Potential Treatment for Barth Syndrome

Retrieved on: 
Thursday, December 21, 2023

BOSTON, Dec. 21, 2023 /PRNewswire/ -- The Barth Syndrome Foundation (BSF), the only patient advocacy organization dedicated to Barth syndrome and saving lives around the world through education, advances in treatment and finding a cure, today announced that it is petitioning the U.S. Food and Drug Administration (FDA) to review the New Drug Application (NDA) for elamipretide, the only potential treatment for Barth syndrome, in a fair, equitable and appropriate manner. Despite compelling evidence that elamipretide has been well-tolerated and has demonstrated clinical benefit in Barth syndrome, and despite ongoing efforts by the Barth Syndrome Foundation and other advocates to engage with regulators, the FDA has refused to review an NDA to date. The petition ran from mid-September to mid-November, and in just two months, garnered nearly 20,000 signatures from individuals across all 50 U.S. states, plus Washington, DC, Puerto Rico, the U.S. Virgin Islands and deployed military personnel.

Key Points: 
  • There are currently no FDA-approved treatments for Barth syndrome, and there are no other potential therapies in clinical development.
  • The Barth Syndrome Foundation and leading scientific thought leaders lobbied for the development of elamipretide for Barth syndrome beginning in 2014.
  • There simply aren't enough people with Barth syndrome, though, to meet the impossible statistical requirements of the FDA to give elamipretide a full drug review.
  • Barth syndrome is a rare, X-linked genetic disorder with an estimated incidence of only 1 in 1 million live births.

Blue Star Families Receives Continued Funding to Amplify Veteran Suicide Prevention Efforts and Mental Health Initiatives

Retrieved on: 
Friday, October 6, 2023

Blue Star Families will receive a second year of funding from Fox Suicide Prevention Grant Program.

Key Points: 
  • Blue Star Families will receive a second year of funding from Fox Suicide Prevention Grant Program.
  • "Blue Star Families is deeply committed to supporting not only our active-duty military and their families but also our Veterans, who have given so much in service to our country.
  • Expand the Blue Star Support Circles Initiative: Enhance and broaden the reach of the BSSC initiative, providing more military families and Veterans with access to vital mental health resources and peer support.
  • Educate and Advocate: Continue to advocate for practices that support Veteran mental health and educate the public about the critical mental health challenges faced by Veterans and their families.

Blue Star Families and Nextdoor Partner to Welcome Military Families on the Move

Retrieved on: 
Thursday, September 14, 2023

Nextdoor (NYSE: KIND) and Blue Star Families (BSF), the nation's largest grass-roots military family support organization, announced a partnership to help military families engage, integrate, and enjoy their local neighborhoods after a move.

Key Points: 
  • Nextdoor (NYSE: KIND) and Blue Star Families (BSF), the nation's largest grass-roots military family support organization, announced a partnership to help military families engage, integrate, and enjoy their local neighborhoods after a move.
  • View the full release here: https://www.businesswire.com/news/home/20230914063989/en/
    Blue Star Families and Nextdoor Partner to Welcome Military Families on the Move (Graphic: Business Wire)
    Each year, 600,000 military families move and these families move, on average, every two to three years.
  • Later this month, Nextdoor will support Blue Star Families’ annual Blue Star Welcome Week, by encouraging neighbors on the platform to support newcomers to the community by sharing their favorite local gems, hotspots and go-to businesses.
  • For more information about Blue Star Welcome Week or to learn more about how to get involved, visit bluestarwelcomeweek.org .

Silver Bull Secures US$9.5M Litigation Funding to Pursue Damages Claim Against the Mexican Government

Retrieved on: 
Wednesday, September 6, 2023

Litigation Funding Agreement (“LFA”) signed with Bench Walk Advisors LLC (“Bench Walk”) to pursue international arbitration claims against Mexico for breaches of its obligations under NAFTA.

Key Points: 
  • Litigation Funding Agreement (“LFA”) signed with Bench Walk Advisors LLC (“Bench Walk”) to pursue international arbitration claims against Mexico for breaches of its obligations under NAFTA.
  • “The substantial litigation funding secured under the LFA is a testament to the strength of Silver Bull’s claims.
  • The US$9.5 million funding facility is non-dilutive to Silver Bull shareholders and will cover the full legal budget of the claim, expert, and ancillary costs, as well as Silver Bull’s operating expenses.
  • Silver Bull held a meeting with Mexican government officials in Mexico City on May 30, 2023, in an attempt to explore amicable settlement options and avoid arbitration.

Bühler and NRGene collaborate to increase competitiveness of black soldier fly industry

Retrieved on: 
Wednesday, September 6, 2023

The two companies are combining their expertise to provide solutions and services to this rapidly evolving industry.

Key Points: 
  • The two companies are combining their expertise to provide solutions and services to this rapidly evolving industry.
  • The partnership between Bühler and NRGene offers BSF producers a comprehensive solution that incorporates Bühler's high-end equipment and engineering capabilities and NRGene's novel genetics and AI-based genomics tools.
  • We are excited to partner with Bühler as we move towards a cost-efficient industry scaleup," says Dr. Gil Ronen, NRGene's CEO and Founder.
  • Black soldier fly is considered one of the most sustainable meat alternatives for carnivorous pets and farm animals.